熱門資訊> 正文
NKGen Biotech收到纳斯达克的违规通知
2024-08-23 04:50
- NKGen Biotech (NASDAQ:NKGN) received a standard notice from Nasdaq that the company is not in compliance with Nasdaq Listing Rule because it had not timely filed its quarterly report on Form 10-Q.
- The Notice indicated that the company has 60 calendar days, or until October 21, 2024, to submit a plan to regain compliance.
- Source: Press Release
More on NKGen Biotech
- Financial information for NKGen Biotech
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。